As the mankind is constantly witnessing the challenges of new diseases to battle and moreover the impending pre-existing diseases challenges like curing life threating disease like Cancer, lifestyle diseases etc…world needs new drugs and hence Clinical Research. Clinical Research Industry serving the mankind with innovative new drugs thereby benefitting the society if not doing a favour.
The reason behind a patient participating in a clinical trial may vary from person to person. Few patients are not satisfied with their current treatment and would like to take a chance to try a new treatment even with the knowledge that it is still being tested. Other patients are motivated by the desire to help others.
A woman in her starting 20s finished many rounds of chemotherapy for the deadliest cancer that’s usually fatal in some months of its detection. Like many, she knew very little regarding clinical trials/studies – except for common beliefs regarding patients as helpless subjects. At home, along with her parents, who knew very little about clinical research, she thought-about her restricted choices.
The woman became happier and more cheerful when she was introduced to a qualified physician by her friend at a distinguished hospital with in-depth oncology research opportunities. Simply learning about the possibilities of clinical trials in her disease created a big difference. The information about cancer research from a verified source completely changed her outlook towards life and gave her a fresh sense of motivation in a tough time.
The motivation to register as a patient in a clinical study differs, of course, as the choice itself is therefore difficult. However, we all know that people get involved in Clinical trials if a physician who is treating them recommends a clinical trial as a possible treatment choice. Most of the patients (84%) state that they’d take into account, engaging in clinical trials if their Physician suggested that they do so, as per a survey conducted by Center for Information and Study on Clinical Research Participation (CISCRP).1 The 2017 CISCRP Public and Patient Perceptions & Insights survey shows that the doctors or specialists, research centre doctors or study employees, and advertisements are generally how clinical study participants come to know about their clinical trial. More precisely, physicians and medical professionals, trusted by patients, are powerful advocates for clinical research.
Apart from the physician’s influence, we know the clinical urgency of a patient’s condition plays a vital role and serves as a powerful motivation for exploring the option of clinical trial enrollment. If someone is incredibly not well and if their treatment choices are very less and life depends on finding a cure, then the person is willing to participate in a clinical trial if given a chance. In clinical trials, no assurances of a cure are made, and the information regarding the trial includes well-crafted language concerning the study, the study drug, safety, and privacy.
People oblige to participate in a clinical trial not solely on the prospect of receiving the latest medical treatments out there however also because they are in a unique position to contribute to the progress of medical knowledge and benefit others. This selfless motivation gets stronger if their illness is genetic and as the result of the clinical analysis could facilitate treatments for their youngsters or grandchildren.
When explaining the benefits of what clinical research can bring to medical science and humanity, communications play a strong role in patient participation. Target patient populations based on their receptivity to certain messages.
In conclusion, a patient/subject who at the end is the most beneficiary from the process and success of Clinical Research.